Clinical Trials on Blepharo Conjunctivitis in Liechtenstein
Total 0 results
Nothing found
Sponsors and Collaborators
- Advanced Life Solutions
- Hazelden Betty Ford Foundation
- Nestlé Health Science Belgium
- Familien Hede Nielsens Fond
- Custom Pharmaceuticals Limited
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- Prof. Jacques SCHRENZEL
- Hospital Samaritano Paulista
- Physip S.A
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- Markham Stouffville Hospital
- UZ Leuven, campus Pellenberg (Belgium)
- IN-JET APS
- Dr. Praveen B.H
- JMI Laboratories
- Janssen (China) Research & Development Center
- The Fred Hollows Foundation, Australia
- Fogarty International Center of the National Institute of Health
- Stannah Stairlifts
- Pedro Gamito
- View Full List
Medical Conditions
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Predictors of Atrial Fibrillation Recurrences
- Painless Hysteroscopy
- Fetus or Neonate Affected by External Version Before Labor
- Skull Base Neoplasms
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Childhood Langerhans Cell Histiocytosis
- Closure; Foramen Ovale
- Endocarditis Infective
- Psoriasis, Arthritic
- Fracture Dislocation of Cervical Spine
- Pulmonary Adenocarcinoma
- Epidemic Hemorrhagic Fever
- Spine Surgeries
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Ewing's Family Tumors
- Tay-Sachs Disease Ganglioside
- Chlamydophila Infections
- Multisystem Proteinopathy
- Gullian Barre Syndrome
- View Full List
Drug Interventions
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Cereport
- Adapalene Gel 0.3%
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Azelastine hydrochloride (BAYR9258)
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Estradiol+Drospirenone
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Vehicle
- Adriamycin
- High dose pantoprazole infusion
- EFV +TVA
- Esomeprazole 40mg before
- Redifferentiation with retinoid acid
- Semapimod
- Qingkailing injection 40 ml
- Chemotherapeutic Agent
- Neihulizumab
- Palliative care group first-line scheme
- Glimepiride
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Austria
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Croatia
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Hungary
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Singapore
- Contract Research Organizations in Togo
- Contract Research Organizations in Zambia
- CRO list by country